A Rare Presentation of Glucose-6-Phosphate Dehydrogenase Deficiency

Neha Tyagi1, Varsha Premkumar1, Manojkumar G Patil1

  • 1Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, IND.

Cureus
|August 5, 2024
PubMed

Insights

Glucose-6-phosphate dehydrogenase (G6PD) deficiency affects 400 million globally. A viral infection and NSAID use triggered acute liver failure and hemolysis in a child with G6PD deficiency.

Area of Science:

  • Genetics and Enzymology
  • Pediatric Gastroenterology and Hematology

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a prevalent X-linked hereditary genetic disorder affecting approximately 400 million individuals worldwide.
  • This condition arises from mutations in the G6PD gene, leading to functional enzyme variants and diverse clinical manifestations.

Observation:

  • A 12-year-old male presented with acute liver failure.
  • The patient subsequently developed signs of hemolysis.
  • Differential diagnoses included acetaminophen toxicity and hepatitis A.

Findings:

  • The clinical presentation was ultimately attributed to an underlying G6PD deficiency.
  • The deficiency was exacerbated by a concurrent viral infection.
  • Simultaneous ingestion of non-steroidal anti-inflammatory drugs (NSAIDs) also contributed to the adverse events.

Implications:

  • Highlights the critical need to consider G6PD deficiency in pediatric patients presenting with acute liver failure and hemolysis, especially when exposed to certain triggers.
  • Emphasizes the potential for drug-induced hemolytic anemia and liver injury in individuals with G6PD deficiency.
  • Underscores the importance of accurate diagnosis and avoidance of inciting agents like NSAIDs and certain infections in managing G6PD deficiency.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
148
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.6K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
224
Energy-requiring Steps of Glycolysis01:20

Energy-requiring Steps of Glycolysis

Glucose is the source of nearly all energy used by organisms. The first step of converting glucose into usable energy is called glycolysis. Glycolysis occurs in the cytosol of the cell over two phases: an energy-requiring phase and an energy-releasing phase. Over the first three steps, glucose is converted into different forms and attached to two phosphate groups donated by two ATP molecules, resulting in an unstable sugar. In the next two stages, the unstable sugar splits into two sugar...
163.3K
Glycolysis: Preparatory Phase01:21

Glycolysis: Preparatory Phase

In cellular metabolism (the complete breakdown of glucose to extract energy),  glycolysis is the first step. Glycolysis takes place in the cytoplasm of both prokaryotic and eukaryotic cells. Glucose enters heterotrophic cells in two ways. One method is through secondary active transport, where the transport takes place against the glucose concentration gradient. The other mechanism uses a group of integral proteins called GLUT proteins, also known as glucose transporter proteins. These...
13.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
911